BARD1 Life Sciences Ltd
ASX:BD1

Watchlist Manager
BARD1 Life Sciences Ltd Logo
BARD1 Life Sciences Ltd
ASX:BD1
Watchlist
Price: 1.04 AUD Market Closed
Market Cap: 83.3m AUD

Operating Margin
BARD1 Life Sciences Ltd

-1 333.5%
Current
-12 946%
Average
3.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 333.5%
=
Operating Profit
-6.8m
/
Revenue
511k

Operating Margin Across Competitors

No Stocks Found

BARD1 Life Sciences Ltd
Glance View

Market Cap
83.3m AUD
Industry
Health Care

BARD1 Life Sciences Ltd. is a biotechnology company, which engages in the provision of medical services. The firm is engaged in research, development, and commercialization of non-invasive diagnostic products for the early detection of cancer. The Company’s technologies include BARD1, SubB2, NET and hTERT. BARD1 is a biomarker platform covering various tumor markers including nucleic acids, proteins, and autoantibodies for early cancer diagnosis.SubB2M is a pan-cancer probe for monitoring cancer treatment response and recurrence across a wide range of cancers. NET is designed to capture and purify biomarkers, including acids, cells, and exosomes. hTERT is an antibody-based assay to detect hTERT, a component of telomerase, in cells.

BD1 Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 333.5%
=
Operating Profit
-6.8m
/
Revenue
511k
What is the Operating Margin of BARD1 Life Sciences Ltd?

Based on BARD1 Life Sciences Ltd's most recent financial statements, the company has Operating Margin of -1 333.5%.

Back to Top